Adoptions in 1967, Supplement to Child Welfare Statistics—1967 , Children's Bureau Statistical Series92, 1968.
2.
Polk, M.: Facts on Adoption in Maryland, Maryland StateDepartment of Social Services, November 1968.
3.
Scrimshaw, N. S. and Gordon, J. E. (ed.): Malnutrition, Learning, and Behavior. Proceedings of an International Conference cosponsored by The Nutrition Foundation, Inc., and the Massachusetts Institute of Technology held at Cambridge, Massachusetts, March 1 to 3, 1967. Cambridge, M. I. T. Press, 1968.
4.
Winick, M.: Changes in nucleic acid and protein content of the human brain during growth . Pediat. Res.2: 352, 1968.
5.
Cravioto, J. and Robles, B.: Evaluation of adaptive and motor behavior during rehabilitation from kwashiorkor. Amer. J. Orthopsychiat.35: 449, 1965.
6.
Hegnauer, H.: Geburtsh. u. Frauenh., 1951.
7.
McIntosh, R. , Merritt, K., Richards , M., Samuels, M. and Bellows, M.: The incidence of congenital malformations; a study of 5,964 pregnancies. Pediatrics14: 505, 1954.
8.
Alexander, G.J. , Machiz, S. and Alexander, R.B.: Inherited abnormalities in three generations of offspring of LSD-treated rats. Fed. Proc.27: 220, 1968.
9.
Cohen, M.M., Hirschhorn, K. and Frosch, W.A.: In vivo and in vitro chromosomal damage induced by LSD-25. New Eng. J. Med.277: 1043, 1967.
10.
Irwin, S. and Egozcue, J.: Chromosomal abnonnalities in leukocytes from LSD-25 users. Science157: 313,1967.
11.
Cohen, M.: Evaluation of drug effects by cytogenetic investigation. In McKhann, G. M., Yaffe, S. J. and Sharon, G. S. (ed.): Drugs and Poisons in Relation to the Developing Nervous System. Proceedings of the conference on drugs and poisons as etiological agents in mental retardation, February 26-March 1, 1967, Palo Alto, California, pp. 37-46. U. S. Department of Health, Education, and Welfare, Public Health Service Publication No. 1791 .
12.
Bender, L. and Siva Sankar, D.V. : Chromosome damage not found in leukocytes of children treated with LSD-25. Science159: 749, 1968 .
13.
Loughman, W. , Sargent, T. and Israelstam, D.: Leukocytes of humans exposed to LSD; lack of chromosomal damage. Ibid.158: 508, 1967 .
14.
Sparkes, R. , Melnyk, J. and Bozzetti, L.T.: Chromosomal effect in vivo of exposure to lysergic acid diethylamide. Ibid.160: 1343, 1968 .
15.
Warkany, J. and Takacs, E.: Lysergic acid diethylamide (LSD); no teratogenicity in rats. Ibid.159: 731, 1968 .
16.
Zellweger, H., McDonald, J. and Abbo, G.: Is lysergic acid diethylamide a teratogen?Lancet2: 1066, 1967.
17.
Apgar, V.: Drugs in pregnancy. JAMA190: 840, 1964 .
18.
Wiener, G., Rider, R., Oppel, W. and Harper, P.: Correlates of low birth weight; psychological status at eight to ten years of age. Pediat. Res.2: 110, 1968.
19.
Barnes, A.: Prevention of congenital anomalies from the point of view of the obstetrician . Second International Conference on Congenital Malformations, New York City, July 14-19, 1963, pp. 377-385.
20.
Pratt, W.: Premarital pregnancy in a metropolitan community. Paper presented at the 1965 meeting of the Population Association of America .
21.
Trends in Illegitimacy, United States—1940-1965. National Center for Health Statistics, Series 21, Number 15, U. S. Department of Health, Education, and Welfare, February 1968.
22.
Apgar, V.: A proposal for a new method of evaluation in the newborn infant. Anesth. Analg.32: 260, 1953.
23.
Drage, J.S. and Berendes, H.: Apgar scores and outcome of the newborn. Pediat. Clin. N. Amer.13: 635, 1966.
24.
Froehlith, L. and Fujikura, T.: Significance of a single umbilical artery . Amer. J. Obstet. Gynec.94: 274, 1966.
25.
Trolle, D.: Decrease of total serum-bilirubin concentration in newborn infants after phenobarbitone treatment. Lancet2: 705, 1968.
26.
Danes, B.S. and Bearn, A.: A genetic cell marker in cystic fibrosis of the pancreas. Lancet1: 1061. 1968.
27.
Wallace, H. , Dooley, S., Thiele , R., Fraser, C. and Eisner, V.: Comprehensive health care of children. Amer. J. Public Health58: 1839, 1968.